Talis Biomedical adds restructuring directors, authorizes potential Ch. 11 filing

Talis Biomedical Corp

Director Heinrich Dreismann resigned effective Aug 1, 2024; Patricia Ferrari and John T. Young Jr. elected.
New Special Restructuring Committee (Ferrari, Young) authorized to settle securities class action, file Ch. 11, and investigate officer/director claims.
Ferrari and Young each receive $35,000/month guaranteed for at least 6 months or until bankruptcy plan confirmed.
Young receives $10,000/yr as Audit Committee chair; both have deep bankruptcy and liquidation experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Heinrich Dreismann

Director

Talis Biomedical Corp

Effective: 2024-08-01
Filed: August 6, 2024, 7:59 PM ET

Accepting the voluntary resignation of Heinrich Dreismann from the Board effective August 1, 2024

Appointed

John T. Young, Jr.

Director

Talis Biomedical Corp

Effective: 2024-07-31
Filed: August 6, 2024, 7:59 PM ET

Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024

Appointed

Patricia Ferrari

Director

Talis Biomedical Corp

Effective: 2024-07-31
Filed: August 6, 2024, 7:59 PM ET

Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Heinrich Dreismann resigned as Director at Talis Biomedical Corp.

Action: resigned
Role: Director

Exact text from the filing

Accepting the voluntary resignation of Heinrich Dreismann from the Board effective August 1, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John T. Young, Jr. was elected as Director at Talis Biomedical Corp.

Action: elected
Role: Director

Exact text from the filing

Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Patricia Ferrari was elected as Director at Talis Biomedical Corp.

Action: elected
Role: Director

Exact text from the filing

Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-24-091874

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.